期刊文献+

MLN4924促进人肺腺癌细胞株A549凋亡的机制研究 被引量:1

In vitro Study on the Mechanism of MLN4924-induced Apoptosis in Human Lung Cancer Cell Line A549
下载PDF
导出
摘要 目的:观察MLN4924对人肺腺癌A549细胞增殖、凋亡的影响,探讨MLN4924促进凋亡的作用机制。方法:不同浓度的MLN4924作用细胞不同时间后,采用CCK-8检测细胞增殖抑制率;Hoechst33342荧光染色、流式细胞仪检测细胞凋亡率及细胞周期;Western blot检测凋亡相关蛋白Caspase-3、NF-κB p65及CDT1相对表达量。结果:MLN4924能够明显抑制A549细胞的增殖,并且具有浓度和时间依赖性。流式细胞仪检测结果显示药物作用后,细胞被阻滞在S期。Western blot结果显示药物作用后细胞内Caspase-3、CDT1蛋白的表达量增加,而NF-κB p65的表达量减少。结论:MLN4924能够明显抑制A549细胞增殖、促进细胞凋亡,其相关机制为MLN4924可阻滞细胞于S期,增加Caspase-3蛋白表达,抑制NF-κB通路的激活。 Objective: To study the effect of MLN4924 on the proliferation and apoptosis of lung epithelial carcinoma A549 cells. Methods: A549 cells were treated with MLN4924 at different concentrations and incubation times. The inhibition rate of cell growth was detected using the cell counting kit-8 (CCK-8) assay. Apoptosis was observed using Hoechst 33342 and flow cytometry. The protein expression of the associated proteins in cell apoptosis, including caspase-3, NF-KB p65, and CDT1, was determined through Westem blot analysis. Results: The proliferation ofA549 cells decreased when the concentration of MLN4924 increased or the incubation time was prolonged. MLN4924 induced S phase cell cycle arrest. The protein expression of the associated proteins caspase-3 and CDT1 was higher than that of the control group. NF-KB p65 was lower than that in the control group. Conclusion: MLN4924 effectively inhibited the proliferation and induced cell apoptosis in A549 cells. MLN4924 treatment induced the S phase cell cycle arrest, increased the caspase-3 protein expression, and inhibited the NF-kB pathway activation.
作者 董扬 黎友伦
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2012年第24期2055-2058,共4页 Chinese Journal of Clinical Oncology
关键词 MLN4924 肺癌 增殖 凋亡 DNA再复制 MLN4924 Lung cancer Proliferation Apoptosis DNA replication
  • 相关文献

参考文献11

  • 1Leung CH, Chan DS, Yang H, et al. A natural product-like inhibitor of NEDDS-activating enzyme[J]. Chem Commun(Camb), 2011, 47 (9):2511-2513.
  • 2Petroski MD. Mechanism-based neddylation inhibitor[J] .Chem Biol, 2010, 17(1):6-8.
  • 3Swords RT, Kelly KR, Smith PG.Inhibition of NEDD8-activating enzyme : a novel approach for the treatment of acute myeloid leukemia [J].Blood, 2010,115 (18):3796-3800.
  • 4Soucy TA, Smith PG, MilhoUen MA, et al. An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer[J]. Nature, 2009, 458(7237):732-736.
  • 5Zhao L, Yue P, Lonial S, et al. The NEDD8-activating enzyme inhibitor, MLN4924, cooperates with TRAIL to augment apoptosis through facilitating c-FLIP degradation in head and neck cancer cells[J]. Mol Cancer Ther, 2011, 10(12):2415-2425.
  • 6Luo Z, Yu G, Lee HW, et al. The Nedd8-Activating Enzyme Inhibitor MLN4924 Induces Autophagy and Apoptosis to Suppress Liver Cancer Cell Growth[J]. Cancer Res, 2012, 72(13):3360-3371.
  • 7Yang D, Tan M, Wang G, et al. The p21-dependent radiosensitization of human breast cancer cells by MLN4924, an investigational inhibitor of NEDD8 activating enzyme[J]. PLoS One, 2012, 7(3): e34079.
  • 8Zhao Y, Sun Y. Targeting the mTOR-DEPTOR Pathway by CRL E3 Ubiquitin Ligases: Therapeutic Application. Neoplasia, 2012, 14(5):360-367.
  • 9BrownellJE, Sintchak MD, GavinJM, et al. Substrate-assisted inhibition of ubiquitin-like protein-activating enzymes: the NEDD8 E1 inhibitor MLN4924 forms a NEDD8-AMP mimetic in situ[J]. Mol Cell, 2010, 37(1):102-111.
  • 10Wei D, Li H, Yu J, et al. Radiosensitization of human pancreatic cancer cells by MLN4924, an investigational NEDD8-activating enzyme inhibitor[J]. Cancer Res, 2012, 72(1):282-293.

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部